{
  "actions": [
    {
      "acted_at": "1977-08-05", 
      "committee": "House Committee on Interstate and Foreign Commerce", 
      "references": [], 
      "status": "REFERRED", 
      "text": "Referred to House Committee on Interstate and Foreign Commerce.", 
      "type": "referral"
    }
  ], 
  "amendments": [], 
  "bill_id": "hr8891-95", 
  "bill_type": "hr", 
  "committees": [
    {
      "activity": [
        "referral", 
        "in committee"
      ], 
      "committee": "House Interstate and Foreign Commerce", 
      "committee_id": "HSIF"
    }
  ], 
  "congress": "95", 
  "cosponsors": [], 
  "enacted_as": null, 
  "history": {
    "awaiting_signature": false, 
    "enacted": false, 
    "vetoed": false
  }, 
  "introduced_at": "1977-08-05", 
  "number": "8891", 
  "official_title": "A bill to amend the Federal Food, Drug, and Cosmetic Act and related provisions of law to improve the protection of the public health and safety with respect to drugs.", 
  "popular_title": null, 
  "related_bills": [
    {
      "bill_id": "hr9541-95", 
      "reason": "identical"
    }
  ], 
  "short_title": "Drug Safety Amendments", 
  "sponsor": {
    "district": "11", 
    "name": "Rogers, Paul G.", 
    "state": "FL", 
    "thomas_id": "00978", 
    "title": "Rep", 
    "type": "person"
  }, 
  "status": "REFERRED", 
  "status_at": "1977-08-05", 
  "subjects": [
    "Consumer protection", 
    "Drug safety and regulation", 
    "Drugs", 
    "Drugs and narcotics", 
    "Exports", 
    "Imports", 
    "Labeling", 
    "Medicated feeds", 
    "Packaging", 
    "Pharmaceutical research"
  ], 
  "subjects_top_term": "Drugs", 
  "summary": {
    "as": "Introduced", 
    "date": "1977-08-05", 
    "text": "Drug Safety Amendments - Amends the Federal Food, Drug, and Cosmetic Act to require: (1) identification and ingredient information on certain drug labels; (2) drug test recordkeeping; (3) origin certification of imported drugs; and (4) release of information used to determine new drugs' safety. Authorizes the Secretary of Health, Education, and Welfare to: (1) give conditional marketing approval to new drugs; (2) conduct drug studies; and (3) suspend approval of new human or animal drugs. Establishes a drug development protocol for testing and marketing of new drugs. Prohibits the export of misbranded drugs unless they meet safety standards established by the Secretary."
  }, 
  "titles": [
    {
      "as": "introduced", 
      "title": "Drug Safety Amendments", 
      "type": "short"
    }, 
    {
      "as": "introduced", 
      "title": "A bill to amend the Federal Food, Drug, and Cosmetic Act and related provisions of law to improve the protection of the public health and safety with respect to drugs.", 
      "type": "official"
    }
  ], 
  "updated_at": "2013-02-02T18:39:00-05:00"
}